Evidence map›Paper›PMID 41275039›Full record

ArticleCellular and molecular life sciences : CMLS2025

Insights into cannabinoid receptor 2 (CB2) anterograde trafficking and pharmacological chaperoning.

Caitlin R M Oyagawa, Braden Woodhouse, Karren C Wood, Michelle Glass, Natasha L Grimsey

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Caitlin R M OyagawaDepartment of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0001-9533-4801
Braden WoodhouseDepartment of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0001-7162-6199
Karren C WoodDepartment of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-9932-2936
Michelle GlassDepartment of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-5997-6898
Natasha L GrimseyDepartment of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. n.grimsey@auckland.ac.nz.ORCID http://orcid.org/0000-0003-3941-4537

Funding

Auckland Medical Research Foundation 1313001Health Research Council of New Zealand 20-006Marsden Fund UOA1507
6 · The paper itself

Abstract

Cannabinoid Receptor 2 (CB

Indexed as

Molecular ChaperonesReceptor, Cannabinoid, CB2AnimalsCannabinoid Receptor AgonistsCell MembraneHEK293 CellsHumansLigandsProtein TransportSignal TransductionCannabinoid Receptor AgonistsLigandsMolecular ChaperonesReceptor, Cannabinoid, CB2Amino acid motifsCannabinoid receptor modulatorsInflammationIntracellular membranesIntracellular traffickingMolecular mechanisms of pharmacological actionPharmacological chaperoneReceptor, cannabinoid, CB2Receptors, G-Protein-CoupledSignal transduction

Identifiers

PMID41275039
PMCPMC12748375

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.